Skip to main content

Animations

MJFF Publications

2791 - 2800 of 6509 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2024
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Differential pathological dynamics triggered by distinct Parkinson patient–derived α-synuclein extracts in nonhuman primates
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adu6050
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Impact of Y chromosome loss on the risk of Parkinson's disease and progression
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105769
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Investigation of the HLA locus in autopsy-confirmed progressive supranuclear palsy
    Journal Name: Immunobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.imbio.2025.152892
    Citation Count: 4
  • Summary Details
    OPEN
    Title: α-Synuclein aggregation decreases cortico-amygdala connectivity and impairs social behavior in mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2024.106702
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Anatomical abnormalities suggest a compensatory role of the cerebellum in early Parkinson's disease
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2025.121121
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease
    Journal Name: The Journal of Prevention of Alzheimer's Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.tjpad.2025.100133
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Segregated basal ganglia output pathways correspond to genetically divergent neuronal subclasses
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.115454
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Corticonigral projections recruit substantia nigra pars lateralis dopaminergic neurons for auditory threat memories
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-025-63132-8
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Structural analyses define the molecular basis of clusterin chaperone function
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41594-025-01631-4
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.98775.3
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.